Wells Fargo & Company GT BIOPHARMA INC Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Number of Shares
10,013
Previous 10,024
0.11%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%